28 June 2017 - A Wagga family is hoping a third attempt to have a cystic fibrosis drug subsidised will be successful.
The Pharmaceutical Benefits Advisory Committee will meet on July 5 to discuss adding new medications to the Pharmaceutical Benefits Scheme, including Orkambi, a drug which could benefit teenager and budding musician Bella Ingram.
Bella and her parents Grant and Lea Ingram have jointed a national campaign to have Orkambi listed on the PBS. Without a PBS listing, the drug costs about $250,000 a year.